Capital Research Global Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.6M | Buy |
102,114
+20,001
| +24% | +$10.5M | 0.01% | 341 |
|
|
2025
Q1 | $52.1M | Buy |
+82,113
| New | +$52.1M | 0.01% | 353 |
|
|
2024
Q4 | – | Sell |
-644,868
| Closed | -$678M | – | 458 |
|
|
2024
Q3 | $678M | Buy |
644,868
+86,081
| +15% | +$90.5M | 0.14% | 124 |
|
|
2024
Q2 | $587M | Buy |
558,787
+164,605
| +42% | +$173M | 0.13% | 132 |
|
|
2024
Q1 | $379M | Sell |
394,182
-12,222
| -3% | -$11.8M | 0.09% | 168 |
|
|
2023
Q4 | $357M | Sell |
406,404
-6,985
| -2% | -$6.13M | 0.09% | 177 |
|
|
2023
Q3 | $340M | Sell |
413,389
-7,655
| -2% | -$6.3M | 0.09% | 181 |
|
|
2023
Q2 | $303M | Buy |
421,044
+4
| +0% | +$2.87K | 0.08% | 184 |
|
|
2023
Q1 | $346M | Buy |
+421,040
| New | +$346M | 0.1% | 171 |
|